【24h】

Does effective management of sleep disorders reduce depressive symptoms and the risk of depression?

机译:有效管理睡眠障碍是否可以降低抑郁症状和抑郁风险?

获取原文
获取原文并翻译 | 示例
           

摘要

The link between co-morbid insomnia and depression has been demonstrated in numerous groups. Insomnia has been associated with: (1) an increased risk of developing subsequent depression; (2) an increased duration of established depression; and (3) relapse following treatment for depression. In addition, specific insomnia symptoms, such as nocturnal awakening with difficulty resuming sleep, are more strongly associated with depression than classic symptoms of insomnia. Participants of a workshop, held at the 6th annual meeting of The International Sleep Disorders Forum: The Art of Good Sleep in 2008, evaluated whether the effective management of sleep disorders could reduce both concurrent depressive symptoms and the risk of developing subsequent depression. Following the workshop, a targeted literature review was conducted. Initial evidence demonstrated that in patients with insomnia and co-morbid depression either pharmacological treatment of insomnia or psychological treatment in the form of cognitive behavioural therapy for insomnia improved both insomnia and depressive symptoms. Although these appeared to be promising treatment strategies, however, of the 27 identified treatment studies, only one large well-designed randomized controlled trial comparing the efficacy of eszopiclone plus fluoxetine with placebo plus fluoxetine demonstrated unequivocal evidence that improvements in insomnia symptoms conferred additive benefits on depressive outcomes. In addition, it was unclear whether any differences exist in efficacy between sedating versus non-sedating pharmacotherapies for insomnia in this patient group. Further studies of sufficient sample size and duration are needed to evaluate combinations of pharmacological (either sedating or non-sedating) and psychological interventions in co-morbid insomnia and depression. This article reviews the level of evidence, recommendations and areas of particular interest for further study and discussion arising from this workshop.
机译:在许多组中都证明了合并症的失眠与抑郁之间的联系。失眠与以下方面有关:(1)患上随后的抑郁症的风险增加; (2)抑郁症持续时间增加; (3)抑郁症治疗后复发。此外,与典型的失眠症状相比,特定的失眠症状(如夜间醒来且难以恢复睡眠)与抑郁症的关联更大。在2008年国际睡眠障碍论坛:良好睡眠的艺术第六届年会上举行的研讨会的参与者,评估了有效管理睡眠障碍是否可以减少并发性抑郁症状和发展成继发性抑郁症的风险。研讨会之后,进行了有针对性的文献综述。初步证据表明,对于患有失眠和合并症的抑郁症患者,无论是药物治疗还是失眠的认知行为疗法形式的心理治疗都能改善失眠和抑郁症状。尽管这些方法似乎是有希望的治疗策略,但是,在27项已确定的治疗研究中,只有一项设计良好的大型随机对照试验比较了埃索匹克隆+氟西汀与安慰剂+氟西汀的疗效,明确证据表明失眠症状的改善可为患者带来额外的益处抑郁的结果。此外,目前尚不清楚该患者组镇静药物治疗与非镇静药物治疗失眠的疗效是否存在差异。需要对足够的样本量和持续时间进行进一步研究,以评估在合并症的失眠和抑郁症中药理学(镇静或非镇静)和心理干预的组合。本文回顾了该研讨会产生的证据,建议和特别感兴趣的领域,以供进一步研究和讨论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号